Publications by authors named "T Matsumaru"

Article Synopsis
  • - Glycolipid antigens are recognized by CD1d on antigen-presenting cells and trigger immune responses in NKT cells through cytokine release.
  • - The study discovered a specific glycolipid (α-GalCer nitro-type) that selectively induces Th2 and Th17 cytokines and has a strong binding affinity to CD1d due to modified fatty acyl groups.
  • - The introduction of natural nitroalkene groups in these glycolipids enhances their interaction with CD1d, which helps explain their unique role in cytokine induction and selectivity.
View Article and Find Full Text PDF

Autonomous navigation systems often struggle in dynamic, complex environments due to challenges in safety, intent prediction, and strategic planning. Traditional methods are limited by rigid architectures and inadequate safety mechanisms, reducing adaptability to unpredictable scenarios. We propose SafeMod, a novel framework enhancing safety in autonomous driving by improving decision-making and scenario management.

View Article and Find Full Text PDF

Splicing modulation by a small compound offers therapeutic potential for diseases caused by splicing abnormality. However, only a few classes of compounds that can modulate splicing have been identified. We previously identified BAY61-3606, a multiple kinase inhibitor, as a compound that relaxes the splicing fidelity at the 3' splice site recognition.

View Article and Find Full Text PDF

Mincle (macrophage-inducible C-type lectin, CLEC4E) is a C-type lectin immune-stimulatory receptor for cord factor, trehalose dimycolate (TDM), which serves as a potent component of adjuvants. The recognition of glycolipids by Mincle, especially their lipid parts, is poorly understood. Here, we performed nuclear magnetic resonance analysis, revealing that titration of trehalose harboring a linear short acyl chain showed a chemical shift perturbation of hydrophobic residues next to the Ca-binding site.

View Article and Find Full Text PDF

This article describes the first total synthesis of luminamicin using a strategy combining chemical degradation with synthesis. Chemical degradation studies provided a sense of the inherent reactivity of the natural product, and deconstruction of the molecule gave rise to a key intermediate, which became the target for chemical synthesis. The core structure of the southern part of luminamicin was constructed by a 1,6-oxa-Michael reaction to form an oxa-bridged ring, followed by coupling with a functionalized organolithium species.

View Article and Find Full Text PDF